Early endothelial and haematological response to cryoplasty compared with balloon angioplasty of the superficial femoral artery - A pilot study

British Journal of Radiology

Volumn 80, Issue 954, 2007, Pages 430-436

  Wildgruber, M ^a   Weiss, W ^a   Berger, H ^a   Eckstein, H H ^a   Wolf, O ^a   Heider, Peter ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BASIC FIBROBLAST GROWTH FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOCHEMICAL MARKER; CELL ADHESION MOLECULE; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEPARIN; IMERON 300; INTERCELLULAR ADHESION MOLECULE; LACTATE DEHYDROGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NONIONIC CONTRAST MEDIUM; PADGEM PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASODILATOR AGENT;

ADULT; AGED; ARTERY ENDOTHELIUM; ARTICLE; BALLOON CATHETER; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CRYOPLASTY; CRYOTHERAPY; DIGITAL SUBTRACTION ANGIOGRAPHY; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOLYSIS; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PILOT STUDY; POPLITEAL ARTERY; POSTOPERATIVE THROMBOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SCREENING TEST; SUPERFICIAL FEMORAL ARTERY;

AGED; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; CELL ADHESION MOLECULES; CHEMOKINE CCL2; CRYOTHERAPY; E-SELECTIN; ENDOTHELIUM; FEMALE; FEMORAL ARTERY; FIBROBLAST GROWTH FACTOR 2; HUMANS; L-LACTATE DEHYDROGENASE; MALE; P-SELECTIN; PILOT PROJECTS; POPLITEAL ARTERY; PROSPECTIVE STUDIES; RECURRENCE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 34548324930     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/12495386     Document Type: Article

References (28)

1. Costanza MJ, Queral LA, Lilly MP, Finn WR. Hemodynamic outcome of endovascular therapy for TransAtlantic InterSociety Consensus type B femoropopliteal arterial occlusive lesions. J Vasc Surg 2004;39:343-50.
2. Fava M, Loyola S, Polydorou A, Papapavlou P, Polydorou A, Mendiz O, et al. Cryoplasty for femoropopliteal arterial disease: late angiographic results of initial human experience. J Vasc Interv Radiol 2004;15:1239-43.
3. Laird J, Jaff MR, Biamino G, McNamara T, Scheinert D, Zetterlund P, et al. Cryoplasty for the treatment of femoropopliteal arterial disease: results of a prospective, multicenter registry. J Vasc Interv Radiol 2005;16:1067-73.
4. Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 2002;252: 283-94.
5. Jovinge S, Hultgardh-Nilsson A, Regnstrom J, Nilsson J. Tumor necrosis factor-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. Arterioscler Thromb Vasc Biol 1997;17:490-7.
6. Neschis DG, Safford SD, Hanna AK, Fox JC, Golden MA. Antisense basic fibroblast growth factor gene transfer reduces early intimal thickening in a rabbit femoral artery balloon injury model. J Vasc Surg 1998;27:126-34.
7. Sinha S, Heagerty AM, Shuttleworth CA, Kielty CM. Expression of latent TGF-beta binding proteins and association with TGF-beta 1 and fibrillin-1 following arterial injury. Cardiovasc Res 2002;53:971-83.
8. Huo Y, Ley K. Adhesion molecules and atherogenesis. Acta Physiol Scand 2001;173:35-43.
9. Tsakiris DA, Tschopl M, Jager K, Haefeli WE, Wolf F, Marbet GA. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. Atherosclerosis 1999;142:193-200.
10. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. J Int Bioethique 2004;15:124-9.
11. Pentecost MJ, Criqui MH, Dorros G, Goldstone J, Johnston KW, Martin EC, et al. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. A statement for health professionals from a Special Writing Group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio-Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart Association. J Vasc Interv Radiol 2003;14:S495-S515.
12. Pai JK, Curhan GC, Cannuscio CC, Rifai N, Ridker PM, Rimm EB. Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection. Clin Chem 2002;48:1781-4.
13. Cheng SW, Ting AC, Ho P. Angioplasty and primary stenting of high-grade, long-segment superficial femoral artery disease: is it worthwhile? Ann Vasc Surg 2003;17:430-7.
14. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 2005;16:331-8.
15. Windecker S, Remondino A, Eberli FR, Juni P, Raber L, Wenaweser P, et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 2005;35:653-62.
16. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-14.
17. Lindner V, Majack RA, Reidy MA. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J Clin Invest 1990;85:2004-8.
18. Ryan ST, Koteliansky VE, Gotwals PJ, Lindner V. Transforming growth factor-beta-dependent events in vascular remodeling following arterial injury. J Vasc Res 2003;40:37-46.
19. Tsakiris DA, Tschopl M, Wolf F, Labs KH, Jager KA, Marbet GA. Platelets and cytokines in concert with endothelial activation in patients with peripheral arterial occlusive disease. Blood Coagul Fibrinolysis 2000;11:165-73.
20. Kataoka T, Honda Y, Bonneau HN, Yock PG, Fitzgerald PJ. New catheter-based technology for the treatment of restenosis. J Interv Cardiol 2002;15:371-9.
21. Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology 2002;60:40-9.
22. Soloff BL, Nagle WA, Moss AJ Jr Henle KJ, Crawford JT. Apoptosis induced by cold shock in vitro is dependent on cell growth phase. Biochem Biophys Res Commun 1987;145:876-83.
23. Grassl ED, Bischof JC. In vitro model systems for evaluation of smooth muscle cell response to cryoplasty. Cryobiology 2005;50:162-73.
24. Danielsson P, Schatz P, Swartbol P, Truedsson L, Danielsson G, Zdanowski Z, et al. Response of inflammatory markers to balloon angioplasty in peripheral arterial occlusive disease. Eur J Vasc Endovasc Surg 2000;20:550-5.
25. Katinioti AA, Tousoulis D, Economou E, Stefanadis C, Trikas A, Tentolouris C, et al. Basic fibroblast growth factor changes in response to coronary angioplasty in patients with stable angina. Int J Cardiol 2002;84:195-9.
26. Laird JR, Biamino G, McNamara T, Scheinert D, Zetterlund P, Moon E, et al. Cryoplasty for the treatment of femoropopliteal arterial disease: extended follow-up results. J Endovasc Ther 2006;13 Suppl 2:II52-9.
27. Venkatasubramanian RT, Grassl ED, Barocas VH, Lafontaine D, Bischof JC. Effects of freezing and cryopreservation on the mechanical properties of arteries. Ann Biomed Eng 2006;34:823-32.
28. Jahnke T. Cryoplasty for the treatment of femoropopliteal arterial disease: will freezing solve the problem of cold feet? J Vasc Interv Radiol 2005;16:1051-4.